NINA LAI: Open Payments
NPI 1093254674 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,988 in 97 payments from 16 companies in 2025. Trend: 2023 $1,685 · 2024 $2,823 · 2025 $1,988
Food & beverage: $1,986Education: $2
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $243 |
| Arcutis Biotherapeutics, Inc. | 6 | $238 |
| UCB, Inc. | 13 | $216 |
| Janssen Biotech, Inc. | 10 | $205 |
| Lilly USA, LLC | 7 | $194 |
| Novartis Pharmaceuticals Corporation | 9 | $162 |
| PFIZER INC. | 11 | $153 |
| Galderma Laboratories, L.P. | 6 | $144 |
| LEO Pharma Inc. | 5 | $110 |
| Regeneron Healthcare Solutions, Inc. | 4 | $104 |
Products named: Zoryve, Bimzelx, TREMFYA, SKYRIZI, CIBINQO, NEMLUVIO, DUPIXENT, TALTZ.
Industry payments across CA — which companies pay providers there.
